{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:23:42Z","timestamp":1784154222303,"version":"3.55.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Neurodevelopmental and mental health disorders such as autism spectrum disorder (ASD), attention-deficit\/hyperactivity disorder (ADHD), and anxiety disorders (AD) are increasingly being studied for their potential links to cancer risk. In this review, we present evidence indicating that ASD alone is not strongly associated with an increased risk of cancer. However, elevated risk is observed in subgroups with co-occurring intellectual disability or congenital anomalies. For ADHD, no direct biological link to cancer has been established, though behavioral factors and medication use remain areas of concern. Anxiety disorders may contribute indirectly to cancer risk through chronic stress and associated health behaviors, with some studies suggesting increased risk for specific cancers, such as prostate or urological cancers. Overall, this review highlights that increased cancer risk appears to be more closely related to co-occurring conditions and lifestyle factors than to the primary diagnoses themselves.<\/jats:p>","DOI":"10.3389\/fonc.2025.1688883","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T05:25:36Z","timestamp":1765776336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the potential link between ADHD, anxiety, autism, and cancer risk"],"prefix":"10.3389","volume":"15","author":[{"given":"Shreya","family":"Wajapeyee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2017-1377","article-title":"Anxiety and mood disorder in children with autism spectrum disorder and adhd","volume":"141","author":"Gordon-Lipkin","year":"2018","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/aur.2894","article-title":"Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit\/hyperactivity disorder: A population-based study","volume":"16","author":"Casseus","year":"2023","journal-title":"Autism Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.04.006","article-title":"Cancer risk in individuals with autism spectrum disorder","volume":"33","author":"Liu","year":"2022","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-023-01054-9","article-title":"Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, pi3k\/mtor, and pak1-regulated mapk","volume":"15","author":"Nussinov","year":"2023","journal-title":"Biophys Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2016.01.001","article-title":"Autism and cancer share risk genes, pathways, and drug targets","volume":"32","author":"Crawley","year":"2016","journal-title":"Trends Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20051166","article-title":"Geneanalytics pathways and profiling of shared autism and cancer genes","volume":"20","author":"Gabrielli","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13229-019-0262-8","article-title":"Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer","volume":"10","author":"Fores-Martos","year":"2019","journal-title":"Mol Autism"},{"key":"B8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jpeds.2014.10.029","article-title":"Risk of cancer in children, adolescents, and young adults with autistic disorder","volume":"166","author":"Chiang","year":"2015","journal-title":"J Pediatr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2012.0050","article-title":"The association between medication for attention-deficit\/hyperactivity disorder and cancer","volume":"23","author":"Steinhausen","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/0897190014543628","article-title":"Attention-deficit\/hyperactivity disorder","volume":"27","author":"Bokor","year":"2014","journal-title":"J Pharm Pract"},{"key":"B11","article-title":"Prescription of controlled substances: benefits and risks","volume-title":"Statpearls","author":"Preuss","year":"2025"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.01.003","article-title":"Cytogenetic effects in children treated with methylphenidate","volume":"230","author":"El-Zein","year":"2005","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.537137","article-title":"Risk of colorectal cancer in patients with attention-deficit hyperactivity disorder: A nationwide, population-based cohort study","volume":"12","author":"Hu","year":"2021","journal-title":"Front Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000042209","article-title":"The causal relationship between six mental disorders and breast cancer risk: A two-sample mendelian randomization study","volume":"104","author":"Hu","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.04.080","article-title":"Genetic correlation and causal associations between psychiatric disorders and lung cancer risk","volume":"356","author":"Shi","year":"2024","journal-title":"J Affect Disord"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.22744","article-title":"Anxiety disorders: A review","volume":"328","author":"Szuhany","year":"2022","journal-title":"Jama"},{"key":"B17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12929-023-00903-9","article-title":"Chronic stress in solid tumor development: from mechanisms to interventions","volume":"30","author":"Yan","year":"2023","journal-title":"J BioMed Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.psyneuen.2006.09.011","article-title":"Psychologic stress, reduced nk cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy","volume":"32","author":"Witek-Janusek","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.738252","article-title":"Chronic stress effects on tumor: pathway and mechanism","volume":"11","author":"Hong","year":"2021","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036370","article-title":"A nationwide population-based cohort study: will anxiety disorders increase subsequent cancer risk","volume":"7","author":"Liang","year":"2012","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12894-016-0187-x","article-title":"Increased risk for urological cancer associated with anxiety disorder: A retrospective cohort study","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Urol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.26574\/maedica.2020.15.2.191","article-title":"Factors influencing delayed diagnosis in oncology","volume":"15","author":"Jidveian Popescu","year":"2020","journal-title":"Maedica (Bucur)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1552815","article-title":"Gene-level connections between anxiety disorders, adhd, and head and neck cancer: insights from A computational biology approach","volume":"16","author":"Lian","year":"2025","journal-title":"Front Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00717","article-title":"The presence of comorbid adhd and anxiety symptoms in autism spectrum disorder: clinical presentation and predictors","volume":"9","author":"Avni","year":"2018","journal-title":"Front Psychiatry"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1688883\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T05:25:37Z","timestamp":1765776337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1688883\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":24,"alternative-id":["10.3389\/fonc.2025.1688883"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1688883","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"1688883"}}